| Absorption |
| Blood-Brain Barrier | BBB- | 0.9431 |
| Human Intestinal Absorption | HIA+ | 0.9356 |
| Caco-2 Permeability | Caco2- | 0.7869 |
| P-glycoprotein Substrate | Non-substrate | 0.6958 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8804 |
| Non-inhibitor | 0.9432 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8959 |
| Distribution |
| Subcellular localization | Lysosome | 0.5866 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7173 |
| CYP450 2D6 Substrate | Non-substrate | 0.8454 |
| CYP450 3A4 Substrate | Non-substrate | 0.6828 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9454 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9582 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9611 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9325 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9502 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9721 |
| Non-inhibitor | 0.9276 |
| AMES Toxicity | Non AMES toxic | 0.9209 |
| Carcinogens | Non-carcinogens | 0.8440 |
| Fish Toxicity | High FHMT | 0.6368 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8451 |
| Honey Bee Toxicity | Low HBT | 0.8054 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | IV | 0.6253 |
| Carcinogenicity (Three-class) | Non-required | 0.6511 |